Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
RESEARCH ARTICLE
Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy
- First Published: 29 April 2025
We found the effect of the number of neoadjuvant chemotherapy cycles (2 vs. ≥ 3 cycles) achieve similar benefits, and the addition of adjuvant chemotherapy after neoadjuvant chemotherapy may have a limited effect on OS in muscle-invasive bladder cancer.
Quality for All: Clinical Trial Enrollment and End-of-Life Care in Solid and Hematologic Malignancies
- First Published: 27 April 2025
Relationship Between Best Tumor Shrinkage and Progression-Free Survival and Overall Survival in Patients With Progressive Midgut Neuroendocrine Tumors Treated With [177Lu]Lu-DOTA-TATE: Ad Hoc Analysis of the Phase III NETTER-1 Trial
- First Published: 24 April 2025
![Relationship Between Best Tumor Shrinkage and Progression-Free Survival and Overall Survival in Patients With Progressive Midgut Neuroendocrine Tumors Treated With [177Lu]Lu-DOTA-TATE: Ad Hoc Analysis of the Phase III NETTER-1 Trial](/cms/asset/64d565b2-46b7-44f7-99f2-78350070c587/cam470744-toc-0001-m.jpg)
We analyzed data from the phase III NETTER-1 study of 177Lu‑DOTATATE for patients with advanced midgut neuroendocrine tumors to explore whether tumor shrinkage is associated with durable efficacy. Although patients receiving 177Lu‑DOTATATE had a progression-free survival (PFS) benefit, no obvious association between best tumor shrinkage and PFS or overall survival was evident. Our results suggest that disease stabilization is an acceptable outcome of 177Lu‑DOTATATE treatment and should not lead to early termination of peptide receptor radionuclide therapy.
Evaluation of Integrin Glycovariants as Biomarkers of Metastasis, Invasion, and Therapy Stratification in Head and Neck Squamous Cell Carcinoma
- First Published: 27 April 2025

There are scarce data about integrin glycosylation in head and neck squamous cell carcinoma. In this study, glycosylation of ITGA2, ITGA3, ITGA5, ITGA6, ITGB1, and ITGB4 was investigated in intraoperative tissue samples using lectin-bioaffinity assays. While integrin glycovariants are abundant in HNSCC tumors and ITGB1-WFL was associated with invasiveness, integrin glycovariants did not directly correlate with metastatic behavior.
The Degree of Extramural Spread of T3 Colon Cancer as a Prognostic Factor: Another Appeal to the American Joint Committee on Cancer
- First Published: 29 April 2025
Network-Based Integrative Analysis to Identify Key Genes and Corresponding Reporter Biomolecules for Triple-Negative Breast Cancer
- First Published: 27 April 2025
The Associations Between Gallstone Disease and Pan-Cancer Incidence Risk Based on Over 13 Million Participants
- First Published: 25 April 2025
BRIEF COMMUNICATION
Associations Between Pre-Existing Cardiovascular Disease and Survival in Patients on Immune Checkpoint Inhibitor Therapy
- First Published: 28 April 2025
RESEARCH ARTICLE
Exploring the Impact of Personality Trait Clusters on the Quality of Life of Breast Cancer Survivors: An 18-Month Prospective Follow-Up Study
- First Published: 02 May 2025
Predictive Value of Radiographic Tumor Burden Score in Hepatocellular Carcinoma Within Milan Criteria After Microwave Ablation: Implications for Long-Term Outcomes and Treatment Planning
- First Published: 24 April 2025

TBS proves to be a valuable predictor for the long-term outcomes of HCC patients meeting Milan criteria after MWA. A higher TBS is associated with a lower long-term survival rate. Notably, among HCC patients meeting Milan criteria, those with TBS > 3 exhibited an extended median RFS time after LMWA treatment.
Bosutinib for Successful Treatment-Free Remission in Chronic Myeloid Leukemia
- First Published: 28 April 2025
Prognostic Value of Pre-Treatment Diffusion Kurtosis Imaging for Progression-Free Survival Prediction in Advanced Nasopharyngeal Carcinoma
- First Published: 25 April 2025
Characterization of the Biochemical Recurrence Prediction Ability and Progression Correlation of Peroxiredoxins Family in Prostate Cancer Based on Integrating Single-Cell RNA-Seq and Bulk RNA-Seq Cohorts
- First Published: 25 April 2025
Search for Mutations Connected With Non-Response to Anti-EGFR Therapy in mCRC in the Morphologically Defined Regions of Primary Tumours
- First Published: 29 April 2025
REVIEW
Targeting Triple-Negative Breast Cancer: Resistance Mechanisms and Therapeutic Advancements
- First Published: 02 May 2025
RESEARCH ARTICLE
Whole Transcriptome Sequencing Analyzes the Interactions of mRNAs and ncRNAs in Cholangiocarcinoma
- First Published: 30 April 2025
CORRECTION
RESEARCH ARTICLE
REVIEW
Gut Microbiota and Hepatocellular Carcinoma: Metabolic Products and Immunotherapy Modulation
- First Published: 02 May 2025
RESEARCH ARTICLE
REVIEW
CORRECTION
RESEARCH ARTICLE
SNAP-Tag–Based Recombinant Photoimmunotherapeutic Agents for the Selective Detection and Killing of Light-Accessible Melanotransferrin-Expressing Melanoma and Triple-Negative Breast Cancer
- First Published: 06 May 2025
Geographic and Socioeconomic Disparities in Emergency Presentations Among Colorectal Cancer Patients in Victoria, Australia
- First Published: 04 May 2025
REVIEW
Integrative Management of Cancer Pain: A Scoping Review of the Literature
- First Published: 03 May 2025
RESEARCH ARTICLE
LINC00908 Inactivates Wnt/β-Catenin Signaling Pathway to Inhibit Prostate Cancer Cell Stemness via Upregulating GSK3B and FBXW2
- First Published: 08 May 2025
Deciphering the Role of Putative Novel miRNAs Encoded From the Newly Found Genomic Regions of T2T-CHM13 in the Progression of Collecting Duct Renal Cell Carcinoma
- First Published: 30 April 2025

We identified 156 novel miRNAs through de novo prediction in the newly discovered genomic regions of T2T-CHM13. These miRNAs target 345 protein-coding genes that are downregulated in collecting duct renal cell carcinoma (cdRCC). The miRNAs may play a role in the disease by altering several key tumor suppressor pathways and targeting multiple tumor suppressor genes.
REVIEW
Regulating Intratumoral Fungi With Hydrogels: A Novel Approach to Modulating the Tumor Microbiome for Cancer Therapy
- First Published: 30 April 2025
RESEARCH ARTICLE
Initial Feasibility and Acceptability of Cancer Pain 101: An Interdisciplinary, Single-Session, Telehealth Intervention for Patients With Cancer-Related Pain
- First Published: 02 May 2025

To improve access to comprehensive pain management, an interdisciplinary team developed a 90-min, single-session, telehealth intervention that combines medical education with behavioral pain treatment modified for patients with cancer. In an open, single-arm pilot study, the intervention was found to be moderately feasible, highly acceptable, and participants described reduced fear regarding opioid use, increased adoption of behavioral pain management strategies, and appreciation for the convenience of telehealth.
SCGB3A1-Epi and KLK10-Epi Crosstalk With Fibroblasts Promotes Liver Metastasis of Breast Cancer and Pancreatic Ductal Adenocarcinoma
- First Published: 13 May 2025
Chidamide, a Histone Deacetylase Inhibitor, Combined With R-GemOx in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (TRUST): A Multicenter, Single-Arm, Phase 2 Trial
- First Published: 02 May 2025
Delving Into Retinoblastoma Genetics: Discovery of Novel Mutations and Their Clinical Impact: Retrospective Cohort Study
- First Published: 02 May 2025
Prognostic Differences and Survival Predictive Models for Mucinous Versus Usual-Type Adenocarcinoma of the Uterine Cervix
- First Published: 02 May 2025
Associations Between Lipid Traits and Breast Cancer Risk: A Mendelian Randomization Study in African Women
- First Published: 02 May 2025
REVIEW
Accelerated Aging in Cancer and Cancer Treatment: Current Status of Biomarkers
- First Published: 05 May 2025
RESEARCH ARTICLE
Hypoxia and Hypoxia-Reoxygenation Potentiate Helicobacter pylori Infection and Gastric Epithelial Cell Proliferation
- First Published: 05 May 2025
REVIEW
Strategies Beyond 3rd EGFR-TKI Acquired Resistance: Opportunities and Challenges
- First Published: 05 May 2025
RESEARCH ARTICLE
Significance of Mutation Spots and Concurrent Gene Mutations on Prognosis and Clinical Outcomes in Myelodysplastic Syndromes With SF3B1 Mutation
- First Published: 08 May 2025
Optimal Primary Prophylaxis for Febrile Neutropenia During Neoadjuvant Cisplatin and 5-Fluorouracil Plus Docetaxel for Esophageal Cancer: A Retrospective Cohort Study
- First Published: 24 April 2025
ARF6 Promotes AML Progression via Activation of PI3K/AKT/mTOR Signaling
- First Published: 24 April 2025
Lack of Routine Health Care Among Adult Survivors of Childhood, Adolescent, and Young Adult Cancers (CAYA): A Nationally Representative Study of 4300 Survivors
- First Published: 07 May 2025

We examined routine health care (no routine checkup in the past year) among a nationally representative sample of childhood, adolescent, and young adult (CAYA) cancer survivors at different life stages. A higher proportion of young adults did not receive routine health care or have a personal doctor, compared to middle-aged or older CAYA survivors. In multivariable models, being a young adult was strongly associated with (1) not receiving routine health care and (2) not having a personal doctor.
Opportunistic Salpingectomy in Non-Gynecologic Surgeries: Barriers and Facilitators From a Healthcare Provider Perspective
- First Published: 09 May 2025

Key barriers to OS implementation in non-gynecological surgeries include unclear invoicing and increased workload, while significant facilitators are the availability of counseling materials and education on counseling and technical performance of OS. Addressing these barriers and leveraging facilitators could enhance OS adoption, potentially reducing ovarian cancer incidence.
Assessing NODM Patients for Early PDAC Diagnosis: Incidence of NODM Before PDAC Diagnosis and Subsequent PDAC Risk
- First Published: 12 May 2025
REVIEW
RESEARCH ARTICLE
Performance Comparison of Droplet Digital PCR and Next-Generation Sequencing for Circulating Tumor DNA Detection in Non-Metastatic Rectal Cancer
- First Published: 09 May 2025
REVIEW
Inside a Metastatic Fracture: Molecular Bases and New Potential Therapeutic Targets
- First Published: 30 April 2025
RESEARCH ARTICLE
Cardiovascular Medication and Health Service Use in Individuals With Cancer: A Retrospective Population-Based Cohort Study
- First Published: 09 May 2025

This study found no difference in cardiovascular disease (CVD) medication use between cancer and the general population. Despite no differences in medication use, the study found higher health service utilisation in individuals with cancer and CVD, suggesting higher need burden and/or limited care integration.
REVIEW
Diagnosis and Treatment of Primary Tracheobronchial Tumors
- First Published: 27 April 2025
Role of Exosome in Solid Cancer Progression and Its Potential Therapeutics in Cancer Treatment
- First Published: 09 May 2025

Exosomes are small extracellular vesicles that facilitate cellular communication and play a significant role in cancer progression by transferring molecules like miRNA and lncRNA within the tumor microenvironment. This review explores how exosomes derived from various cells influence solid cancer growth by activating pathways critical to tumor proliferation and metastasis. Understanding these interactions may reveal new therapeutic approaches for treating solid tumors.
RESEARCH ARTICLE
Associations Between Personality Traits and Longitudinal Change in Physical Function in Survivors of Childhood Cancer
- First Published: 09 May 2025

Exercise interventions for survivors of childhood cancer focus on improving cardiovascular fitness and muscle strength but often do not consider personality factors that influence longitudinal maintenance of function. In this study of longitudinal performance change after participation in exercise intervention in survivors, associations were observed between higher levels of conscientiousness and improvement in walking speed ~4 years post-exercise intervention.
Association Between Pre-Diagnostic Delay and Survival Among Patients With Esophageal and Gastric Cancer Treated With Curative Intent During the COVID19 Pandemic
- First Published: 09 May 2025
Real-World Data on the p.Gly17Val RHOA Mutation in Diagnosing T Follicular Helper Cell Lymphomas
- First Published: 10 May 2025

Tfh lymphomas, including angioimmunoblastic T-cell lymphoma, often present with symptoms resembling autoimmune conditions. The p.Gly17Val RHOA (G17V) mutation is commonly found in these lymphomas and can aid diagnosis, offering faster results, especially in patients with specific clinical features like lymphadenopathy, fever, and skin rash.
Predictors of Financial Toxicity Trajectories in Patients With Pancreatic Cancer: A Latent Class Growth Analysis
- First Published: 04 May 2025
Enhanced IL36RN Expression and Its Association With Immune Microenvironment Predicts Poor Prognosis in Gastric Cancer
- First Published: 10 May 2025
Multi-Targeted Kinase Inhibitor Therapy in Pediatric Bone and Soft Tissue Sarcoma Patients—A Single Centre Experience
- First Published: 09 May 2025
Global Burden of Lip and Oral Cavity Cancer From 1990 to 2021 and Projection to 2040: Findings From the 2021 Global Burden of Disease Study
- First Published: 10 May 2025
Outcome of Patients With Cancer-Associated Pulmonary Embolism: Results From the Regional Pulmonary Embolism Registry
- First Published: 25 April 2025

The results of our investigation have shown that patients with newly diagnosed malignant disease with acute PE and patients with known malignant disease and PE had much higher hospital mortality and more severe acute PE presentation than patients without malignant disease. We have also shown that patients with known malignant disease had a lower chance of thrombolysis treatment than patients without malignant disease.
Optimizing Deep Learning Models for Luminal and Nonluminal Breast Cancer Classification Using Multidimensional ROI in DCE-MRI—A Multicenter Study
- First Published: 10 May 2025
Evaluation of Efficacy of Neoadjuvant Immunochemotherapy for Cervical Metastatic Squamous Cell Carcinoma of Unknown Primary
- First Published: 01 May 2025
Inhibition of Purine Metabolism Promotes the Differentiation of Neuroblastoma Driven by MYCN
- First Published: 12 May 2025